Multimodal anion exchange matrices

Patent metadata

Field	Value
Publication number	US-11718643-B2
Application number	US-201314441129-A
Country	US
Kind code	B2
Filing date	Nov 11, 2013
Priority date	Nov 13, 2012
Publication date	Aug 8, 2023
Grant date	Aug 8, 2023

Abstract

The invention discloses a separation matrix which comprises a plurality of separation ligands, defined by the formula R1-L1-N(R3)-L2-R, immobilized on a support, wherein R1 is a five- or six-membered, substituted or non-substituted ring structure or a hydroxyethyl or hydroxypropyl group; L1 is either a methylene group or a covalent bond; R2 is a five- or six-membered, substituted or non-substituted ring structure; L2 is either a methylene group or a covalent bond; R3 is a methyl group; and wherein if R1 is a hydroxyethyl group and L1 is a covalent bond, R2 is a substituted aromatic ring structure or a substituted or non-substituted aliphatic ring structure.

First claim

The invention claimed is:

1. A separation matrix comprising a plurality of separation ligands defined by formula (I)
R 1 -L 1 -N(R 3 )-L 2 -R 2   (I)

immobilized on a support via the amine group of formula (I),
wherein R 1 is a hydroxyethyl group or a five- or six-membered, substituted or non-substituted ring structure;
L 1 is either a methylene group or a covalent bond;
R 2 is a five- or six-membered, substituted or non-substituted ring structure;
L 2 is either a methylene group or a covalent bond; and
R 3 is a methyl group;

wherein said ligands in free form have an octanol-water distribution coefficient (lg P) of 1.8-5;
wherein if R 1 is a hydroxyethyl group, L 1 is a covalent bond and R 2 is a substituted aromatic ring structure or a substituted or non-substituted aliphatic ring structure; and
wherein the separation ligands are defined by formula (IV) or (V):

2. The separation matrix according to claim 1 , wherein said ligands in free form have an octanol-water distribution coefficient (lg P) of 2-4.

3. The separation matrix according to claim 1 , wherein the immobilized separation ligands are immobilized on the support Su via a spacer Sp, as defined in formula (VI)

4. The separation matrix according to claim 3 , wherein the spacer Sp comprises a chain of 2-8 carbon atoms, optionally at least one of interrupted by and ending in one or more ether groups and optionally substituted by one or more hydroxyl groups.

5. The separation matrix according to claim 1 , wherein the support comprises porous particles.

6. The separation matrix according to claim 1 , wherein the support comprises a porous membrane.

7. The separation matrix of claim 1 , wherein the plurality of separation ligands are defined by formula (IV).

8. The separation matrix of claim 1 , wherein the plurality of separation ligands are defined by formula (V).

9. The separation matrix of claim 1 , wherein the separation matrix has an antibody yield of at least 90%.

10. A method of separating one or more antibodies from one or more other compounds in a liquid sample, comprising the steps of a) providing a mobile phase comprising said antibodies and other compound(s); and b) contacting said mobile phase with a separation matrix according to claim 1 .

11. The method of claim 10 , wherein the conductivity of said mobile phase is at least 10 mS/cm.

12. The method of claim 10 , wherein said mobile phase comprises an antibody-containing eluate from a previous affinity chromatography step, ion exchange step, multimodal chromatography step, or hydrophobic interaction chromatography step.

13. The method of claim 10 , wherein the separation matrix is provided in a chromatography column, the mobile phase is passed through said column by at least one of gravity and pumping, and the antibodies are recovered in the flow-through of the column.

14. The method of claim 10 , wherein the separation matrix is provided in a chromatography column, in step b) the mobile phase is passed through said column by at least one of gravity and pumping and at least part of the antibodies adsorb to the column and in a further step c) an elution buffer is passed through the column and antibodies are recovered in the elution buffer after passage through the column.

15. The method of claim 10 , wherein in step b) a suspension of matrix particles is contacted with the mobile phase, in a further step c) the matrix particles are separated from the mobile phase by sedimentation, centrifugation or under the influence of a magnetic field and in an optional further step d) the antibodies are recovered in the separated mobile phase.

Assignees

• Ge Healthcare Bioprocess R&D Ab
• Cytiva Bioprocess R & D Ab

Inventors

• Maloisel Jean-Luc
• Rodrigo Gustav
• Noren Bjorn
• Kumbhar Virendra

Classifications

• C07K1/165 Primary

  mixed-mode chromatography · CPC title

• B01D15/327

  with hydrophobic interaction · CPC title

• B01D15/363

  Anion-exchange · CPC title

• B01D15/3847 Primary

  Multimodal interactions · CPC title

• B01J20/265

  modified or post-treated polymers (polymer carriers or substrates subjected to further impregnating or coating B01J20/3208) · CPC title